Showing results (121-130 of 715) with videos related to

Sort By:
Pageof 72
Clinical Lymphoma, Myeloma & Leukemia|February 9, 2013
Prognostic model to identify patients with myelofibrosis at the highest risk of transformation to acute myeloid leukemiaAlfonso Quintás-Cardama, Hagop Kantarjian, Sherry Pierce, et al.
Blood|May 31, 2007
Farnesyl transferase inhibitor resistance probed by target mutagenesisTal Raz, Valentina Nardi, Mohammad Azam, et al.
Leukemia Research|July 20, 2002
Response of idiopathic hypereosinophilic syndrome to treatment with imatinib mesylatePatricia Ault, Jorge Cortes, Charles Koller, et al.
Cancer|March 9, 2010
Central nervous system prophylaxis in adults with acute lymphoblastic leukemia: current and emerging therapiesElias Jabbour, Deborah Thomas, Jorge Cortes, et al.
Cancer Journal (Sudbury, Mass.)|December 14, 2011
Evolution of therapies for chronic myelogenous leukemiaFabio P S Santos, Hagop Kantarjian, Alfonso Quintás-Cardama, et al.
Annals of Internal Medicine|December 21, 2006
New insights into the pathophysiology of chronic myeloid leukemia and imatinib resistanceHagop M Kantarjian, Moshe Talpaz, Francis Giles, et al.
Blood Reviews|July 3, 2014
Practical issues surrounding the explosion of tyrosine kinase inhibitors for the management of chronic myeloid leukemiaMichael S Mathisen, Hagop M Kantarjian, Jorge Cortes, et al.
Brain, Behavior, & Immunity - Health|November 21, 2022
Evaluation of delayed LNFPIII treatment initiation protocol on improving long-term behavioral and neuroinflammatory pathology in a mouse model of Gulf War IllnessJessica M Carpenter, Kyle A Brown, Lukas Veltmaat, et al.
Blood|July 1, 2006
Myelodysplastic syndromes and acute leukemia developing after imatinib mesylate therapy for chronic myeloid leukemiaCraig Kovitz, Hagop Kantarjian, Guillermo Garcia-Manero, et al.
Leukemia Research|February 9, 2013
Chromosome 5q deletion is extremely rare in patients with myelofibrosisKoichi Takahashi, Jorge Cortes, Sherry Pierce, et al.
Pageof 72